⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TNGX News
Tango Therapeutics, Inc.
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TNGX
Form 8-K
sec.gov
TNGX
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
globenewswire.com
TNGX
ERAS
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
globenewswire.com
ERAS
TNGX
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
globenewswire.com
TNGX
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
globenewswire.com
TNGX
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
globenewswire.com
TNGX
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
globenewswire.com
TNGX
Tangoe and Kubex Partner to Deliver Advanced Cloud and Kubernetes Optimization Through Tangoe One Cloud
businesswire.com
TNGX
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
globenewswire.com
TNGX